Review: The Role of Cytokines in the Catabolic Consequences of Infection and Injury
Tóm tắt
Từ khóa
Tài liệu tham khảo
Buck M., 1996, Tumor necrosis factor‐α inhibits collagen α 1(I) gene expression and wound healing in a murine model of cachexia, Am J Pathol, 149, 195
Dinarello CE, 1991, Interleukin‐1 and interleukin‐1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627
Gauldie J., 1987, Purified interleukin‐1 (IL‐1) from human monocytes stimulates acute‐phase protein synthesis by rodent hepatocytes in vitro, Immunology, 60, 203
Warner SJC, 1987, Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells, J Immunol, 139, 1911, 10.4049/jimmunol.139.6.1911
Ruschen S., 1989, Spontaneous and LPS‐stimulated production of intracellular IL‐1β by sinovial macrophages in rheumatoid arthritis is inhibited by IFN‐γ, Clin Exp Immunol, 76, 246
Ghezzi P., 1988, IL‐1 induces IL‐1. III. Specific inhibition of IL‐1 production by IFN‐γ, J Immunol, 140, 4238, 10.4049/jimmunol.140.12.4238
Knudsen PJ, 1987, Glucocorticoids inhibit transcriptional and post‐transcriptional expression of interleukin‐1 in U937 cells, J Immunol, 139, 4129, 10.4049/jimmunol.139.12.4129
Knudsen PJ, 1984, Prostaglandins inhibit post‐transcriptional interleukin‐1 synthesis by increasing intracellular cyclic adenosine monophosphate, J Immunol, 137, 3189, 10.4049/jimmunol.137.10.3189
Richards C., 1991, Cytokine control of acute phase protein expression, Eur Cytokine Network, 2, 89
Jablons DM, 1989, IL‐6/IFN‐β‐2 as a circulating hormone. Induction by cytokine administration in humans, J Immunol, 142, 1542, 10.4049/jimmunol.142.5.1542
Watson J., 1978, The genetic mapping of a defective LPS response gene in C3H/HeJ mice, J Immunol, 120, 422, 10.4049/jimmunol.120.2.422
Freudenberg MA, 1993, Bacterial Endotoxins: Recognition and Effector Mechanisms, 197
Katschinski T., 1992, Gamma interferon mediates Propionibacterium acnes‐induced hypersensitivity to lipopolysaccharide in mice, Infect Immun, 60, 1994, 10.1128/iai.60.5.1994-2001.1992
Wherry JC, 1991, Regulation of gamma interferon production by natural killer cells in scid mice : Roles of tumor necrosis factor and bacterial stimuli, Infect Immun, 59, 1709, 10.1128/iai.59.5.1709-1715.1991
Freudenberg MA, 1991, Tumor necrosis factor alpha mediates lethal activity of killed Gram‐negative and Gram‐positive bacteria in D‐galactosamine‐treated mice, Infect Immun, 59, 2110, 10.1128/iai.59.6.2110-2115.1991
Freudenberg MA, 1991, Gamma interferon production in endotoxin‐responder and non‐responder mice during infection, Infect Immun, 59, 3484, 10.1128/iai.59.10.3484-3491.1991
Heinzel FP, 1990, The role of IFN‐γ in the pathology of experimental endotoxemia, J Immunol, 145, 2920, 10.4049/jimmunol.145.9.2920
Doherty GM, 1992, Evidence for IFN‐γ as a mediator of the lethality of endotoxin and tumor necrosis factor‐α, J Immunol, 149, 1666, 10.4049/jimmunol.149.5.1666
Bucklin SE, 1994, Participation of IFN‐γ in the pathogenesis of LPS lethality, Prog Clin Biol Res, 338, 399
Kohler J., 1993, IFN‐γ involvement in the severity of gram‐negative infections in mice, J Immunol, 151, 916, 10.4049/jimmunol.151.2.916
Zhao Y., 1995, Impact of interferon‐γ receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis, J Immunol, 155, 5736, 10.4049/jimmunol.155.12.5736
Flynn JL, 1993, An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection, J Exp Med, 178, 2249, 10.1084/jem.178.6.2249
Matthys P., 1995, Anti‐gamma interferon and anti‐interleukin‐6 antibodies affect staphylococcal enterotoxin B‐induced weight loss, hypoglycemia, and cytokine release in D‐galactosamine‐sensitized and unsensitized mice, Infect Immun, 63, 1158, 10.1128/iai.63.4.1158-1164.1995
Langstein HN, 1991, The roles of γ‐interferon and tumor necrosis factor α in an experimental model of cancer cachexia, Cancer Res, 51, 2302
Krigel RL, 1988, A phase I study of recombinant interleukin 2 plus recombinant β‐interferon, Cancer Res, 48, 3875
Legaspi A., 1985, Proteolysis of skeletal muscle in response to acute elevation of plasma cortisol in man, Surg Forum, 36, 16
Kayali AG, 1987, Sensitivity of myofibrillar protein to glucocorticoid‐induced muscle proteolysis, Am J Physiol, 252, E621
Nelson DH, 1989, Endocrinology, Vol II, 1660
Baumann H., 1987, Interaction among hepatocyte‐stimulating factors, interleukin‐1, and glucocorticoids for regulation of acute phase proteins in human hepatoma (Hep G2) cells, J Immunol, 139, 4122, 10.4049/jimmunol.139.12.4122
Hall‐Angeras M., 1991, Effect of the glucocorticoid receptor antagonist RU 38486 on muscle protein breakdown in sepsis, Surgery, 109, 468
Zamir O., 1993, Effects of tumor necrosis factor or interleukin‐1 on muscle amino acid uptake and the role of glucocorticoids, Surg Gynecol Obstet, 177, 27
Philibert D., RI 38486: An original multifaceted antihormone in vivo. IN Adrenal Steroid Antagonism, 77
Baracos VE, 1995, Activation of the ATP‐ubiquitin‐proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma, Am J Physiol, 268, E996
Price SR, 1994, Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNA in rat muscle, Am J Physiol, 267, C955, 10.1152/ajpcell.1994.267.4.C955
Price SR, 1996, Necessary but not sufficient: The role of glucocorticoids in the acidosis‐induced increase in levels of mRNAs encoding proteins of the ATP‐dependent proteolytic pathway in rat muscle, Miner Electrolyte Metab, 22, 72
Wing SS, 1994, 14‐kDa ubiquitin‐conjugating enzyme: Sructure of the rat gene and regulation upon fasting and by insulin, Am J Physiol, 267, E39
Ling PR, 1996, Metabolic changes in rats during a continuous infusion of recombinant interleukin 1, Am J Physiol, 270
Ling PR, 1997, Mechanisms of host wasting induced by administration of cytokines in rats, Am J Physiol, 272, E333
Darling G., 1990, Cachectic effects of recombinant human tumor necrosis factor in rats, Cancer Res, 50, 4008
Fattori E., 1994, Defective inflammatory response in interleukin‐6‐deficient mice, J Exp Med 1994;, 180, 1243
Kozak W., 1997, Sickness behavior in mice deficient in interleukin‐6 during turpentine abscess and influenza pneumonitis, Am J Physiol, 272, R661
Hall‐Agnerås M., 1990, Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis, Surgery, 108, 460
Tessitore L., 1994, Pharmacological interference with cancer cachexia, Biochem J, 299, 71
Hotamisligil GS, 1994, Tumor necrosis factor α: A key component of the obesity‐diabetes link, Diabetes, 43, 1271, 10.2337/diab.43.11.1271
Breuillé D., 1993, Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis, Am J Physiol, 265, E660
Lang CH, 1992, Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output, Endocrinology, 130, 43, 10.1210/endo.130.1.1727716
Douglas RG, 1991, Effects of recombinant IGF‐I on protein and glucose metabolism in rTNF‐infused lambs, Am J Physiol, 261, E606
Olefsky JM, 1990, Diabetes Mellitus, 121
Kadowaki M., 1996, Acute effect of epinephrine on muscle proteolysis in perfused rat hindquarters, Am J Physiol, 270, E961
Cooney RN, 1994, Interleukin‐1 receptor antagonist prevents sepsis‐induced inhibition of protein synthesis, Am J Physiol, 267, E636
Jurasinki CV, 1995, Insulin‐like growth factor I accelerates protein synthesis in skeletal muscle during sepsis, Am J Physiol, 269, E977
Lang CH, 1996, IL‐1 receptor antagonist attenuates sepsis‐induced alterations in the IGF system and protein synthesis, Am J Physiol, 270, E430
Wojnar MM, 1995, Alterations in the insulin‐like growth factor system in trauma patients, Am J Physiol, 268, R970
Fan J., 1995, Regulation of insulin‐like growth factor (IGF)‐I and IGF‐binding proteins by tumor necrosis factor, Am J Physiol, 269, R1204
Fan J., 1995, Regulation of insulin‐growth factor (IGF)‐I mRNA and peptide, and IGF‐I binding proteins by interleukin‐1, Am J Physiol, 270, R621
Dardevet D., 1994, Insulin‐like growth factor‐1 and insulin resistance in skeletal muscle of adult and old rats, Endocrinology, 134, 1475, 10.1210/endo.134.3.8119189
Vary TC, 1996, Regulation of peptide‐chain initiation in muscle during sepsis by interleukin‐1 receptor antagonist, Am J Physiol, 271, E513
Cooney RN, 1995, Prevention of skeletal muscle catabolism in sepsis does not impair visceral protein metabolism, Am J Physiol, 270, E621
Lang CH, 1996, Central interleukin‐1 partially mediates endotoxin‐induced changes in glucose metabolism, Am J Physiol, 271, E309
Jefferson LS, 1974, Insulin in the regulation of protein turnover in heart and skeletal muscle, Fed Proc, 33, 1098
Fulks R., 1975, Effects of insulin, glucose and amino acids on protein turnover in rat diaphragm, J Biol Chem, 250, 290, 10.1016/S0021-9258(19)42013-9
Narahara HT, 1974, The actions of insulin, trypsin and electrical stimulation on amino acid transport in muscle, J Biol Chem, 249, 5435, 10.1016/S0021-9258(20)79747-4
Larbaud D., 1996, Euglycemic hyperinsulinemia and hyperaminoacidemia decrease skeletal muscle ubiquitin mRNA in goats, Am J Physiol, 271, E505
Jepson MM, 1988, Relationship between glutamine concentration and protein synthesis in rat skeletal muscle, Am J Physiol, 255, E166
Karner J., 1989, Glutamine‐containing dipeptides as infusion substrates in the septic state, Surgery 1989;, 106, 893
Hickson RC, 1996, Glutamine interferes with glucocorticoid‐induced expression of glutamine synthetase in skeletal muscle, Am J Physiol, 270, E912
McDevitt TM, 1995, Purification and characterization of a lipid‐mobilizing factor associated with cachexia‐inducing tumors in mice and humans, Cancer Res, 55, 1458